Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YMC017 in Hypertensive and Hypercholesterolemic Patients
NCT02968160Phase 4Terminated
- Sponsor
- Yuhan
- Start
- Oct 2016
- Primary completion
- Feb 2018
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of telmisartan + rosuvastatin in hypertension (HTN) and hypercholesterolemia, sponsored by Yuhan. Primary endpoint: Proportion of subjects reaching siSBP and LDL-C treatment goals at 8 weeks. Started Oct 2016; status: terminated.
02
Drugs
telmisartan + rosuvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02968160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02968160.